BDTB Bodhi Tree Biotechnology Inc
Services-Management Consulting Services · OTC · SEC CIK 2041531 · Fiscal year ends 09/30
Financial factors as of 2026-06-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY48.0%
TTM net income YoY44.9%
TTM EPS YoY-20.8%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin—
Operating margin-310.2%
Net margin-313.6%
FCF margin—
EBITDA margin—
Returns
ROE-161.5%
ROA-156.6%
ROIC (approx.)-899.0%
Asset turnover0.50x
Leverage & solvency
Liabilities / assets24.6%
Debt / equity0.00x
Current ratio—
Interest coverage—
Cash quality & payout
Operating cash flow / net income1.00x
Accruals ratio-0.7%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q3*2026-06-30 | 2026Q2*2026-03-31 | 2026Q12025-12-31 | 2025Q4*2025-09-30 | 2025Q32025-06-30 | 2025Q22025-03-31 | 2025Q12024-12-31 | 2025Q1*2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $10,000 | $15,000 | $0 | $12,000 | $0 | $0 | $5,000 | $20,000 |
| SG&A expense | $33,195 | $42,934 | $52,949 | $22,687 | $19,975 | $52,179 | $69,777 | $91,565 |
| Operating income | -$23,195 | -$27,934 | -$52,949 | -$10,687 | -$19,975 | -$52,179 | -$64,777 | -$71,565 |
| Pretax income | -$23,194 | -$27,932 | -$52,948 | -$10,687 | -$19,974 | -$52,178 | -$64,777 | -$71,565 |
| Income tax | $0 | $1,263 | — | $0 | $800 | $1,250 | — | — |
| Net income | -$23,194 | -$29,196 | -$52,948 | -$10,687 | -$20,774 | -$53,428 | -$64,777 | -$71,565 |
| EPS (basic) | 0.00 | 0.00 | -0.01 | — | 0.00 | 0.00 | 0.00 | — |
| EPS (diluted) | 0.00 | 0.00 | -0.01 | — | 0.00 | 0.00 | 0.00 | — |
| Weighted avg. shares (diluted) | 25.44M | 25.44M | 25.44M | — | 25.44M | 25.44M | 25.44M | — |
| Banking | ||||||||
| Net interest income | $1 | $2 | $1 | $0 | $1 | $1 | — | — |
| Balance sheet | ||||||||
| Cash & equivalents | $3,986 | $22,750 | $47,366 | $109,404 | $119,516 | $144,165 | $194,293 | $259,570 |
| Total assets | $18,323 | $40,517 | $69,713 | $119,161 | $129,848 | $150,622 | — | $269,327 |
| Current liabilities | $4,500 | $3,500 | $3,500 | — | — | — | — | $500 |
| Total liabilities | $4,500 | $3,500 | $3,500 | $0 | $0 | $0 | — | $500 |
| Shareholders' equity | $13,823 | $37,017 | $66,213 | $119,161 | $129,848 | $150,622 | $204,050 | $268,827 |
| Shares outstanding | 25.44M | 25.44M | 25.44M | 25.44M | 25.44M | 25.44M | — | 25.44M |
| Cash flow statement | ||||||||
| Operating cash flow | -$18,764 | -$24,616 | -$62,038 | -$10,112 | -$24,649 | -$50,128 | -$65,277 | -$90,989 |
| Financing cash flow | — | — | — | — | — | — | — | $280,780 |
Free plan shows the latest 8 periods; Pro shows all 10 🔒
· This company does not report gross profit in XBRL.
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.